MEK inhibitor U0126 interferes with immunofluorescence analysis of apoptotic cell death

Cytometry

Volumn 48, Issue 4, 2002, Pages 179-184

  Blank, Norbert ^a   Burger, Renate ^a   Duerr, Birgit ^a   Bakker, Frank ^a   Wohlfarth, Anika ^a   Dumitriu, Ingrid ^a   Kalden, Joachim R ^a   Herrmann, Martin ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Annexin V; Apoptosis; Fluorescence; MEK inhibitor; Necrosis; U0126

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 (2 CHLORO 4 IODOANILINO) N CYCLOPROPYLMETHOXY 3,4 DIFLUOROBENZAMIDE; CELL SURFACE RECEPTOR; GROWTH FACTOR; INTERLEUKIN 6; LIPOCORTIN 5; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE KINASE; PHOSPHATIDYLSERINE; PROPIDIUM IODIDE;

ANALYTIC METHOD; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CYTOFLUOROMETRY; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME REGULATION; FLOW CYTOMETRY; FLUORESCENCE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; MONONUCLEAR CELL; PRIORITY JOURNAL; T LYMPHOCYTE;

ANNEXIN A5; APOPTOSIS; BUTADIENES; CELL DIVISION; CELL SURVIVAL; ENZYME INHIBITORS; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; INTERLEUKIN-6; MAP KINASE KINASE KINASE 1; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASES; NECROSIS; NITRILES; PLASMACYTOMA; PROTEIN-SERINE-THREONINE KINASES; REPRODUCIBILITY OF RESULTS; SCATTERING, RADIATION; STAINING AND LABELING; T-LYMPHOCYTES; TUMOR CELLS, CULTURED;

EID: 0036702530     PISSN: 01964763     EISSN: None     Source Type: Journal    
DOI: 10.1002/cyto.10127     Document Type: Article

References (24)

1. Cohen JJ. Apoptosis. Immunol Today 1993;14:126-130.
2. Koopman G, Reutelingsperger CP, Kuijten GA, Keehnen RM, Pals ST, van Oers MH. Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood 1994; 84:1415-1420.
3. Martin SJ, Reutelingsperger CP, McGahon AJ, Rader JA, van Schie RC, LaFace DM, et al. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: Inhibition by overexpression of Bcl-2 and Abl. J Exp Med 1995;182:1545-1556.
4. Bratton DL, Fadok VA, Richter DA, Kailey JM, Guthrie LA, Henson PM. Appearance of phosphatidylserine on apoptotic cells requires calcium-mediated nonspecific flip-flop and is enhanced by loss of the aminophospholipid translocase. J Biol Chem 1997;272:26159-26165.
5. Zamzami N, Susin SA, Marchetti P, Hirsch T, Gomez-Monterrey I, Castedo M, et al. Mitochondrial control of nuclear apoptosis. J Exp Med 1996;183:1533-1544.
6. Zhivotovsky B, Gahm A, Ankarcrona M, Nicotera P, Orrenius S. Multiple proteases are involved in thymocyte apoptosis. Exp Cell Res 1995;221:404-412.
7. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 1991;139:271-279.
8. Saklatvala J, Rawlinson LM, Marshall CJ, Kracht M. Interleukin 1 and tumour necrosis factor activate the mitogen-activated protein (MAP) kinase kinase in cultured cells. FEBS Lett 1993;334:189-192.
9. Fairhurst RM, Daeipour M, Amaral MC, Nel AE. Activation of mitogen-activated protein kinase/ERK-2 in phytohaemagglutin in blasts by recombinant interleukin-2: Contrasting features with CD3 activation. Immunology 1993;79:112-118.
10. Hieronymus T, Blank N, Gruenke M, Winkler S, Haas JP, Kalden JR, et al. CD 95-independent mechanisms of IL-2 deprivation-induced apoptosis in activated human lymphocytes. Cell Death Differ 2000;7:538-547.
11. Duncia JV, Santella JB, 3rd, Higley CA, Pitts WJ, Wityak J, Frietze WE, et al. MEK inhibitors: The chemistry and biological activity of U0126, its analogs, and cyclization products. Bioorg Med Chem Lett 1998;8: 2839-2844.
12. Favata MF, Horiuchi KY, Manos EJ, Daulerio AJ, Stradley DA, Feeser WS, et al. Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J Biol Chem 1998;273:18623-18632.
13. Karihaloo A, O'Rourke DA, Nickel C, Spokes K, Cantley LG. Differential MAPK pathways utilized for HGF- and EGF-dependent renal epithelial morphogenesis. J Biol Chem 2001;276:9166-9173.
14. Davies SP, Reddy H, Caivano M, Cohen P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 2000;351(Pt 1):95-105.
15. Burger R, Neipel F, Fleckenstein B, Savino R, Ciliberto G, Kalden JR, et al. Human herpesvirus type 8 interleukin-6 homologue is functionally active on human myeloma cells. Blood 1998;91:1858-1863.
16. Honemann D, Chatterjee M, Savino R, Bommert K, Burger R, Gramatzki M, et al. The IL-6 receptor antagonist SANT-7 overcomes bone marrow stromal cell-mediated drug resistance of multiple myeloma cells. Int J Cancer 2001;93:674-680.
17. Aubin JE. Autofluorescence of viable cultured mammalian cells. J Histochem Cytochem 1979;27:36-43.
18. Nokubo M, Nagy I, Kitani K, Ohta M. Characterization of the autofluorescence of rat liver plasma membranes. Biochim Biophys Acta 1988; 939:441-448.
19. Hawkins EP, Hawkins HK, Armstrong D. Lymphocyte autofluorescence: A screening procedure for neurodegenerative diseases. Pediatr Neurol 1986;2:160-166.
20. Dudley DT, Pang L, Decker SJ, Bridges AJ, Saltiel AR. A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc Natl Acad Sci USA 1995;92:7686-7689.
21. Hagenhofer M, Germaier H, Hohenadl C, Rohwer P, Kalden JR, Herrmann M. UV-B irradiated cell lines execute programmed cell death in various forms. Apoptosis 1998;3:123-132.
22. Elstein KH, Zucker RM. Comparison of cellular and nuclear flow cytometric techniques for discriminating apoptotic subpopulations. Exp Cell Res 1994;211:322-331.
23. Dai Y, Yu C, Singh V, Tang L, Wang Z, McInistry R, et al. Pharmacological inhibitors of the mitogen-activated protein kinase (MAPK) kinase/MAPK cascade interact synergistically with UCN-01 to induce mitochondrial dysfunction and apoptosis in human leukemia cells. Cancer Res 2001;61:5106-5115.
24. Alessi DR, Cuenda A, Cohen P, Dudley DT, Saltiel AR. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J Biol Chem 1995;270:27489-27494.